Literature DB >> 25037934

Multilocus sequence typing for the analysis of clonality among Candida albicans strains from a neonatal intensive care unit.

Eun Song Song1, Jong Hee Shin2, Hee-Chang Jang3, Min Ji Choi4, Soo Hyun Kim4, Marie-Elisabeth Bougnoux5, Christophe d'Enfert6, Young Youn Choi1.   

Abstract

Nosocomial Candida albicans infections are a significant problem in neonatal intensive care units (NICUs). We investigated the clonality of C. albicans isolates recovered over an 8-year period from neonates at a NICU. We also validated multilocus sequence typing (MLST) compared with pulsed-field gel electrophoresis (PFGE) for the genotyping of C. albicans strains from the same NICU. A total of 43 clinical isolates (10 blood, 19 urine, and 14 other) were obtained from 43 neonates between 2005 and 2012. Clonal strains were defined as the isolation of two or more strains with identical or similar genotypes as determined with both MLST and PFGE. Using MLST, the 43 isolates yielded 25 diploid sequence types (DSTs) and 10 DSTs were shared by 28 isolates (65.1%). Among the 28 isolates sharing 10 DSTs, isolates from each of seven DSTs had the same or similar PFGE pattern. In addition, two sets of isolates that differed by MLST at only one locus had the same or similar PFGE pattern. Overall, when the MLST and PFGE results were combined, 22 isolates (51.2%) shared eight genotypes, suggesting clonal strains. Strains from each of seven genotypes (total, 19 isolates) were isolated among the 22 clonal strains within a 6-month period, whereas three strains of one genotype were obtained over a 3-year interval. Our findings suggest that horizontal transmission of C. albicans may occur more frequently than vertical transmission among NICU patients and that MLST appears to be a useful method for genotyping C. albicans strains isolated from NICU patients.
© The Author 2014. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Candida albicans; genotyping; multilocus sequence typing; neonatal intensive care unit; pulsed-field gel electrophoresis

Mesh:

Year:  2014        PMID: 25037934     DOI: 10.1093/mmy/myu028

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  5 in total

Review 1.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Reduction in Percentage of Clusters of Candida albicans and Candida parapsilosis Causing Candidemia in a General Hospital in Madrid, Spain.

Authors:  Pilar Escribano; Carlos Sánchez-Carrillo; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

3.  Whole Genome-Based Amplified Fragment Length Polymorphism Analysis Reveals Genetic Diversity in Candida africana.

Authors:  Anuradha Chowdhary; Ferry Hagen; Cheshta Sharma; Abdullah M S Al-Hatmi; Letterio Giuffrè; Domenico Giosa; Shangrong Fan; Hamid Badali; Maria Rosa Felice; Sybren de Hoog; Jacques F Meis; Orazio Romeo
Journal:  Front Microbiol       Date:  2017-04-03       Impact factor: 5.640

4.  Molecular Fingerprinting Studies Do Not Support Intrahospital Transmission of Candida albicans among Candidemia Patients in Kuwait.

Authors:  Mohammad Asadzadeh; Suhail Ahmad; Noura Al-Sweih; Ziauddin Khan
Journal:  Front Microbiol       Date:  2017-02-21       Impact factor: 5.640

5.  Genetic diversity assessed using PFGE, MLP and MLST in Candida spp. candidemia isolates obtained from a Brazilian hospital.

Authors:  Heliara Maria Spina Canela; Bárbara Cardoso; Miliane Rodrigues Frazão; Juliana Pfrimer Falcão; Lucia Helena Vitali; Roberto Martinez; Márcia Eliana da Silva Ferreira
Journal:  Braz J Microbiol       Date:  2021-02-20       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.